Haruna Fujinami

Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma

S. Iida, H. Komatsu, T. Ishida, 2019, International Journal of Hematology.

Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study

N. Ohte, S. Iida, H. Komatsu, 2020, EJHaem.

Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutation

S. Iida, H. Komatsu, S. Kusumoto, 2022, International Journal of Hematology.

Exophiala dermatitidis Fungemia Diagnosed Using Time-of-flight Mass Spectrometry during Chemotherapy for Malignant Lymphoma and Successful Treatment with Voriconazole

S. Iida, H. Komatsu, T. Ishida, 2019, Internal medicine.

Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy

S. Iida, Yasuhito Tanaka, H. Komatsu, 2020, Journal of clinical and experimental hematopathology : JCEH.